Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$4.08 | -$4.08 | -$4.08 |
Q2 2025 | 1 | -$3.53 | -$3.53 | -$3.53 |
Q3 2025 | 1 | -$3.53 | -$3.53 | -$3.53 |
Q4 2025 | 1 | -$3.53 | -$3.53 | -$3.53 |
ENDRA Life Sciences Inc. last posted its earnings results on Friday, November 15th, 2024. The company reported $-5.85 earnings per share for the quarter, topping analysts' consensus estimates of $-62.3 by $56.45. The company had revenue of 0 for the quarter and had revenue of 0 for the year. ENDRA Life Sciences Inc. has generated $-1 earnings per share over the last year ($-1.11 diluted earnings per share) and currently has a price-to-earnings ratio of -0.17. ENDRA Life Sciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/21/2024 | Q3 2024 | -$9.54 | $100,000 | $0 | ||
08/14/2024 | Q2 2024 | -$122.50 | -$0.21 | 122.29 | $100,000 | $0 |
05/14/2024 | Q1 2024 | -$0.27 | -$0.26 | 0.01 | $0 | |
03/28/2024 | Q4 2023 | -$0.36 | -$0.14 | 0.22 | $428,408 | |
11/14/2023 | Q3 2023 | -$0.43 | -$0.40 | 0.03 | $0 | |
08/14/2023 | Q2 2023 | -$0.55 | -$0.43 | 0.12 | $0 | |
05/15/2023 | Q1 2023 | -$51.00 | -$0.93 | 50.07 | $0 | |
03/16/2023 | Q4 2022 | -$1.03 | $0 | |||
11/14/2022 | Q3 2022 | -$60.00 | -$1.10 | 58.9 | $0 | |
08/15/2022 | Q2 2022 | -$50.00 | -$1.17 | 48.83 | $0 | |
05/12/2022 | Q1 2022 | -$70.00 | -$1,327,722.12 | -1327652.12 | $0 | |
03/30/2022 | Q4 2021 | -$1.60 | -$1.48 | 0.12 | $0 | |
11/15/2021 | Q3 2021 | -$70.00 | -$1.27 | 68.73 | $0 | |
08/12/2021 | Q2 2021 | -$70.00 | -$1.54 | 68.46 | $0 | |
05/17/2021 | Q1 2021 | -$70.00 | -$1.20 | 68.8 | $0 | |
03/25/2021 | Q4 2020 | -$140.00 | -$1.88 | 138.12 | $0 | |
11/16/2020 | Q3 2020 | -$160.00 | -$2.73 | 157.27 | $0 | |
08/14/2020 | Q2 2020 | -$5.40 | -$3.93 | 1.47 | $0 | |
05/14/2020 | Q1 2020 | -$6.60 | -$5.77 | 0.83 | $0 | |
03/26/2020 | Q4 2019 | -$350.00 | -$8.36 | 341.64 | $0 |
ENDRA Life Sciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
In the previous quarter, ENDRA Life Sciences Inc. (:NDRA) reported $-5.85 earnings per share (EPS) to beat the analysts' consensus estimate of $-62.3 by $56.45.
The conference call for ENDRA Life Sciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for ENDRA Life Sciences Inc.'s latest earnings report can be read online.
ENDRA Life Sciences Inc. (:NDRA) has a recorded net income of $0. ENDRA Life Sciences Inc. has generated $-1.11 earnings per share over the last four quarters.
ENDRA Life Sciences Inc. (:NDRA) has a price-to-earnings ratio of -0.17 and price/earnings-to-growth ratio is 0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED